Navigation Links
AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine
Date:5/16/2008

ED Rebecca Haag's Statement for National HIV Vaccine Awareness Day, May 18

WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Twenty-six years into the AIDS epidemic, someone is newly infected with HIV every 13 minutes in the U.S. On Sunday, May 18, HIV Vaccine Awareness Day, AIDS Action, one of five national partners in the National Institute of Allergy and Infectious Disease (NIAID) HIV Vaccine Research Education Initiative, urges everyone to help end the AIDS epidemic by participating in the search for an HIV Vaccine. We also thank the numerous volunteers, community educators, scientists and advocates for their efforts to further HIV vaccine research.

AIDS Action's support for continued and increased investment in HIV vaccine research is unwavering. Basic HIV vaccine research must remain one of the many prevention strategies being pursued at a national level. We will continue to advocate for HIV vaccine research here in Washington, DC and raise awareness of and support for HIV vaccine research across the country.

The best long-term hope for controlling the AIDS epidemic is the development of safe, effective and affordable HIV vaccines. Historically, vaccines have been the most powerful weapon against diseases like polio, measles and Hepatitis B. In fact, no major viral epidemic has been defeated without one.

Vaccine research is a difficult, complicated and iterative process that takes many years. It took 47 years to develop a vaccine for polio, and 42 for measles. This past September, the phase II Merck Step Trial was halted due to ineffectiveness, raising a storm of scientific and media inquiry. While the results were disappointing, the Step trial itself and its safety mechanisms were successfully implemented. The failure of one vaccine candidate does not signify the failure of all HIV vaccine research. This setback, as have others, may be a stepping stone to future success.

AIDS Action is committed to increase awareness of the need for an HIV vaccine, improve the public's knowledge of vaccine research and create support for current and future HIV vaccine trials. We must focus on increasing awareness among African Americans, Latinos, women and men who have sex with men. The epidemic is taking an increasingly devastating toll on these disproportionately affected populations, yet African Americans, Latinos, women, and men who have sex with men are largely underrepresented in HIV vaccine research clinical trials. A large HIV vaccine trial will require thousands of participants of all races/ethnicities, genders and socioeconomic backgrounds to ensure that the vaccine works in all populations. Therefore, community support is essential in efforts to break down stigma and myths about HIV vaccine research.

As a National Partner, AIDS Action will work to establish leadership and support for HIV vaccine research and its clinical trials. Through its membership network of AIDS service organizations, health departments, health educators, and community-based organizations across the country, AIDS Action is perfectly poised to increase HIV vaccine awareness among key influencers and community and national leaders.

So, here is what you can do to help. Find information about HIV vaccine research efforts, Talk about HIV vaccine research with your family and friends, support a trial volunteer, or contact your local trial site to become a volunteer or joining a community advisory board. We encourage everyone to become involved in HIV Vaccine Awareness Day.

Learn more about events in your area, how you can help, and the facts about HIV vaccine research at http://www.bethegeneration.org and http://www.aidsaction.org.


'/>"/>
SOURCE AIDS Action
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Announces Possible Delisting Action by NASDAQ
2. Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery
3. DeepFX(TM) and ActiveFX(TM) Fractional Resurfacing Featured at Annual Meeting of The American Society Of Aesthetic Plastic Surgery
4. MIPSolutions, Inc. Reduces Expense and Development Time Associated With Precious Metal Extraction
5. PA Governor Says Financial Analysis Shows Nothing Stands in Way of Senate Action to Help Pennsylvanias Uninsured
6. AVMA Recognizes Public Veterinarians Urges Congressional Action
7. Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People
8. Secretary Cortes Calls Latino Community to Action Against Ailing Health Care System
9. J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers
10. LMS CALM(R) receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report
11. Brookhaven scientists explore brains reaction to potent hallucinogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: